WuXi PharmaTech (Cayman) Inc. Deferred Revenue
WuXi PharmaTech (Cayman) Inc. had Deferred Revenue of $27.67 million as of 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2015-04-15
- 2014-12-31: Deferred Revenue, Current $27.67M.
- 2013-12-31: Deferred Revenue, Current $28.15M.
- 2012-12-31: Deferred Revenue, Current $17.05M.
- 2011-12-31: Deferred Revenue, Current $15.88M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2014-12-31 | $27.67M 20-F · filed 2015-04-15 |
| 2013-12-31 | $28.15M 20-F · filed 2015-04-15 |
| 2012-12-31 | $17.05M 20-F · filed 2014-04-15 |
| 2011-12-31 | $15.88M 20-F · filed 2013-04-17 |
| 2010-12-31 | $8.82M 20-F · filed 2012-04-20 |
| 2009-12-31 | $4.55M 20-F · filed 2011-04-27 |